Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baumstein
S Block
J Whitworth

Showing results (591-600 of 601) with videos related to

Pageof 61
Sort By:
Alzheimer'S Research & Therapy|March 28, 2024
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factorsImogen J Swift, Rosa Rademakers, NiCole Finch, et al.
Mayo Clinic Proceedings|March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S Block, Robert A Vierkant, Peter F Rambau, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
JAMA Oncology|October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer, Ellen L Goode, Matthew S Block, et al.
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Cancer Research|November 26, 2013
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Bridget Charbonneau, Matthew S Block, William R Bamlet, et al.
Nature Communications|March 29, 2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerHui Shen, Brooke L Fridley, Honglin Song, et al.
Lancet (London, England)|December 17, 2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 61

Showing results (591-600 of 601) with videos related to

Sort By:
Pageof 61
Alzheimer'S Research & Therapy|March 28, 2024
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factorsImogen J Swift, Rosa Rademakers, NiCole Finch, et al.
Mayo Clinic Proceedings|March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S Block, Robert A Vierkant, Peter F Rambau, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
JAMA Oncology|October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer, Ellen L Goode, Matthew S Block, et al.
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Cancer Research|November 26, 2013
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Bridget Charbonneau, Matthew S Block, William R Bamlet, et al.
Nature Communications|March 29, 2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerHui Shen, Brooke L Fridley, Honglin Song, et al.
Lancet (London, England)|December 17, 2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 61